U.S., April 12 -- ClinicalTrials.gov registry received information related to the study (NCT06924541) titled 'Choline Dose Ranging in Postmenopausal Women' on Aug. 19, 2024.
Brief Summary: This study will use a randomized placebo-controlled trial to examine smaller doses of choline and whether a signal in the brain is detectable using fMRI. This study will examine if an even smaller doses of choline can show these similar brain activation and connectivity patterns to the 1650 mg dose. This will be a dose ranging study of 550 mg and 1100 mg oral choline compared to placebo.
Study Start Date: Sept. 01, 2024
Study Type: INTERVENTIONAL
Condition:
Menopause
Intervention:
DIETARY_SUPPLEMENT: Choline
Each subject gets one of two oral choli...